WARNING: “Buffett Indicator” flashing for first time in 50 years

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW

Douglas P. Baker net worth and biography

Douglas Baker Biography and Net Worth

CFO of OptimizeRx

Doug joined OptimizeRx as CFO in May 2014. He spent the previous 18 years as CFO of Applied Nanotech Holdings, Inc., a public company specializing in nanotechnology research and development.

Hands-on CFO with excellent strategic vision and strong technical and problem-solving skills.

Specialties/Strengths: SEC Reporting, Registration Statements, Investor Relations, Forecasting and Budgeting, Strategic Planning and Business Planning, Fundraising Structures, Mergers and Acquisitions, Restructuring/Turnarounds, Sarbanes Oxley Compliance, Start-ups, Taxation, Litigation Support, Board of Directors.

What is Douglas P. Baker's net worth?: The estimated net worth of Douglas P. Baker is at least $219,948.36 as of September 14th, 2021. Mr. Baker owns 44,796 shares of OptimizeRx stock worth more than $219,948 as of December 22nd. This net worth approximation does not reflect any other assets that Mr. Baker may own. Learn More about Douglas P. Baker's net worth.
How do I contact Douglas P. Baker?: The corporate mailing address for Mr. Baker and other OptimizeRx executives is 400 WATER STREET SUITE 200, ROCHESTER MI, 48307. OptimizeRx can also be reached via phone at (248) 651-6568 and via email at [email protected]. Learn More on Douglas P. Baker's contact information.
Has Douglas P. Baker been buying or selling shares of OptimizeRx?: Douglas P. Baker has not been actively trading shares of OptimizeRx within the last three months. Most recently, Douglas P. Baker sold 14,000 shares of the business's stock in a transaction on Tuesday, October 5th. The shares were sold at an average price of $82.88, for a transaction totalling $1,160,320.00. Learn More on Douglas P. Baker's trading history.
Who are OptimizeRx's active insiders?: OptimizeRx's insider roster includes Douglas Baker (CFO), William Febbo (CEO), Miriam Paramore (Insider), Stephen Silvestro (Insider), and Patrick Spangler (Director). Learn More on OptimizeRx's active insiders.
Are insiders buying or selling shares of OptimizeRx?: During the last twelve months, OptimizeRx insiders bought shares 1 times. They purchased a total of 20,000 shares worth more than $100,200.00. During the last twelve months, insiders at the sold shares 1 times. They sold a total of 4,000 shares worth more than $60,760.00. The most recent insider tranaction occured on December, 12th when CEO William J Febbo bought 20,000 shares worth more than $100,200.00. Insiders at OptimizeRx own 6.1% of the company. Learn More about insider trades at OptimizeRx.
Information on this page was last updated on 12/12/2024.

Douglas P. Baker Insider Trading History at OptimizeRx

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/5/2021	Sell	14,000	$82.88	$1,160,320.00
9/28/2021	Sell	2,000	$74.66	$149,320.00
9/21/2021	Sell	4,000	$70.59	$282,360.00
9/14/2021	Sell	3,768	$65.57	$247,067.76	44,796
9/8/2021	Sell	10,000	$67.25	$672,500.00	48,564
8/31/2021	Sell	4,000	$66.62	$266,480.00	50,796
8/24/2021	Sell	4,000	$61.50	$246,000.00	58,796
8/20/2021	Sell	5,000	$58.45	$292,250.00
7/27/2021	Sell	3,000	$52.58	$157,740.00	76,796
7/20/2021	Sell	3,000	$50.90	$152,700.00
7/8/2021	Sell	13,435	$56.05	$753,031.75	69,361
6/28/2021	Sell	3,421	$63.00	$215,523.00	82,796
6/24/2021	Sell	4,000	$60.00	$240,000.00	86,217
6/7/2021	Sell	14,500	$52.62	$762,990.00	75,717
5/18/2021	Sell	14,500	$45.85	$664,825.00	75,717
1/29/2021	Sell	5,032	$47.25	$237,762.00	85,902
1/13/2021	Sell	5,000	$38.89	$194,450.00	85,937
11/11/2020	Sell	15,000	$24.05	$360,750.00	75,705
9/2/2020	Sell	10,000	$20.00	$200,000.00	80,705
8/13/2020	Sell	10,000	$18.00	$180,000.00	100,671
8/6/2020	Sell	10,000	$17.01	$170,100.00	100,671
7/16/2020	Sell	6,667	$15.00	$100,005.00	82,671
8/10/2018	Sell	4,784	$12.01	$57,455.84
5/11/2017	Buy	10,000	$0.77	$7,700.00	50,000
11/14/2016	Buy	10,000	$0.85	$8,500.00	40,000
6/7/2016	Buy	10,000	$1.05	$10,500.00	30,000
11/17/2014	Buy	10,000	$0.88	$8,800.00
6/5/2014	Buy	10,000	$1.50	$15,000.00

Douglas P. Baker Buying and Selling Activity at OptimizeRx

OptimizeRx Company Overview

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

Today's Range

Now: $4.91

$4.62

$5.06

50 Day Range

MA: $5.37

$3.83

$6.71

2 Week Range

Now: $4.91

$3.78

$16.65

Volume

290,325 shs

Average Volume

162,423 shs

Market Capitalization

$90.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.34